Jurisic V, Vukovic V, Obradovic J, Gulyaeva L, Kushlinskii N, Djordjevic N
J Oncol. 2020; 2020:1973241.
PMID: 32256580
PMC: 7104312.
DOI: 10.1155/2020/1973241.
Rajan A, Gibson-Corley K, Choi A, Ofori-Amanfo G, Ten Eyck P, Espinosa-Cotton M
J Oncol. 2019; 2019:5859680.
PMID: 31320902
PMC: 6607721.
DOI: 10.1155/2019/5859680.
Tsai C, Tsai C, Yi J, Kao H, Huang Y, Wang C
Sci Rep. 2019; 9(1):5197.
PMID: 30914776
PMC: 6435638.
DOI: 10.1038/s41598-019-41396-7.
Ali Beg M, Fahdil S, Yadav P, Shukla K, Mohan A, Saxena A
Asian Pac J Cancer Prev. 2019; 20(3):825-830.
PMID: 30912007
PMC: 6825767.
DOI: 10.31557/APJCP.2019.20.3.825.
Jurisic V, Obradovic J, Pavlovic S, Djordjevic N
Anal Cell Pathol (Amst). 2018; 2018:6192187.
PMID: 30406002
PMC: 6204164.
DOI: 10.1155/2018/6192187.
EGFR promoter exhibits dynamic histone modifications and binding of ASH2L and P300 in human germinal matrix and gliomas.
Erfani P, Tome-Garcia J, Canoll P, Doetsch F, Tsankova N
Epigenetics. 2015; 10(6):496-507.
PMID: 25996283
PMC: 4622924.
DOI: 10.1080/15592294.2015.1042645.
Sequence analysis of the Ras-MAPK pathway genes SOS1, EGFR & GRB2 in silver foxes (Vulpes vulpes): candidate genes for hereditary hyperplastic gingivitis.
Clark J, Tully S, Marshall H
Genetica. 2014; 142(6):517-23.
PMID: 25377643
DOI: 10.1007/s10709-014-9798-x.
Eradication of Human Ovarian Cancer Cells by Transgenic Expression of Recombinant and Controlled by Promoter: Novel Strategy for Targeted Therapy of Cancer.
Malecki M, Dahlke J, Haig M, Wohlwend L, Malecki R
J Genet Syndr Gene Ther. 2014; 4(6):152.
PMID: 24587967
PMC: 3938193.
DOI: 10.4172/2157-7412.1000152.
Optimization of PCR conditions for amplification of GC-Rich EGFR promoter sequence.
Obradovic J, Jurisic V, Tosic N, Mrdjanovic J, Perin B, Pavlovic S
J Clin Lab Anal. 2013; 27(6):487-93.
PMID: 24218132
PMC: 6807403.
DOI: 10.1002/jcla.21632.
Egr-1 is a critical regulator of EGF-receptor-mediated expansion of subventricular zone neural stem cells and progenitors during recovery from hypoxia-hypoglycemia.
Alagappan D, Balan M, Jiang Y, Cohen R, Kotenko S, Levison S
ASN Neuro. 2013; 5(3):183-93.
PMID: 23763269
PMC: 3786424.
DOI: 10.1042/AN20120032.
Somatic deletions of the polyA tract in the 3' untranslated region of epidermal growth factor receptor are common in microsatellite instability-high endometrial and colorectal carcinomas.
Deqin M, Chen Z, Nero C, Patel K, Daoud E, Cheng H
Arch Pathol Lab Med. 2012; 136(5):510-6.
PMID: 22540299
PMC: 3807134.
DOI: 10.5858/arpa.2010-0638-OA.
Oncogenic KRAS impairs EGFR antibodies' efficiency by C/EBPβ-dependent suppression of EGFR expression.
Derer S, Berger S, Schlaeth M, Schneider-Merck T, Klausz K, Lohse S
Neoplasia. 2012; 14(3):190-205.
PMID: 22496619
PMC: 3323897.
DOI: 10.1593/neo.111636.
EGFR isoforms and gene regulation in human endometrial cancer cells.
Albitar L, Pickett G, Morgan M, Wilken J, Maihle N, Leslie K
Mol Cancer. 2010; 9:166.
PMID: 20579378
PMC: 2907331.
DOI: 10.1186/1476-4598-9-166.
Estrogen-dependent transcription of the NEL-like 2 (NELL2) gene and its role in protection from cell death.
Choi E, Kim D, Kim J, Kim D, Kim J, Seol O
J Biol Chem. 2010; 285(32):25074-84.
PMID: 20538601
PMC: 2915743.
DOI: 10.1074/jbc.M110.100545.
Down-regulation of epidermal growth factor receptor by selective expansion of a 5'-end regulatory dinucleotide repeat in colon cancer with microsatellite instability.
Baranovskaya S, Martin Y, Alonso S, Pisarchuk K, Falchetti M, Dai Y
Clin Cancer Res. 2009; 15(14):4531-7.
PMID: 19584170
PMC: 2885604.
DOI: 10.1158/1078-0432.CCR-08-1282.
Signaling inputs to progesterone receptor gene regulation and promoter selectivity.
Daniel A, Knutson T, Lange C
Mol Cell Endocrinol. 2009; 308(1-2):47-52.
PMID: 19549591
PMC: 3924551.
DOI: 10.1016/j.mce.2009.01.004.
Progesterone receptors act as sensors for mitogenic protein kinases in breast cancer models.
Dressing G, Hagan C, Knutson T, Daniel A, Lange C
Endocr Relat Cancer. 2009; 16(2):351-61.
PMID: 19357196
PMC: 3931451.
DOI: 10.1677/ERC-08-0281.
Exon 19 of EGFR mutation in relation to the CA-repeat polymorphism in intron 1.
Sueoka-Aragane N, Imai K, Komiya K, Sato A, Tomimasu R, Hisatomi T
Cancer Sci. 2008; 99(6):1180-7.
PMID: 18422739
PMC: 11159769.
DOI: 10.1111/j.1349-7006.2008.00804.x.
Loss of p53 induces epidermal growth factor receptor promoter activity in normal human keratinocytes.
Bheda A, Creek K, Pirisi L
Oncogene. 2008; 27(31):4315-23.
PMID: 18391986
PMC: 2572188.
DOI: 10.1038/onc.2008.65.
Progesterone receptor rapid signaling mediates serine 345 phosphorylation and tethering to specificity protein 1 transcription factors.
Faivre E, Daniel A, Hillard C, Lange C
Mol Endocrinol. 2008; 22(4):823-37.
PMID: 18202149
PMC: 2276470.
DOI: 10.1210/me.2007-0437.